Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 19-Nov-24 5:43 PM View:  | Olivo Alicia C General Counsel | Neogenomics Inc. (NEO) | 15-Nov-24 | Sale (Planned) | 5,175 | $15.36 | $79,475.10 | (12%) 42.3K to 37.13K | |
| 04-Sep-24 4:08 PM View: | Olivo Alicia C General Counsel | Neogenomics Inc. (NEO) | 01-Sep-24 | Payment of Exercise | 1,666 | -- | -- | (4%) 43.81K to 42.15K | |
| 19-Aug-24 4:17 PM View: | Olivo Alicia C General Counsel | Neogenomics Inc. (NEO) | 15-Aug-24 | Sale (Planned) | 1,040 | $16.05 | $16,695.40 | (2%) 44.85K to 43.81K | |
| 19-Aug-24 4:19 PM View: | Smith Christopher M Chief Executive Officer | Neogenomics Inc. (NEO) | 15-Aug-24 | Payment of Exercise | 33,130 | -- | -- | (5%) 679.43K to 646.3K | |
| 13-Aug-24 4:34 PM View: | Perez David Brian Director | Neogenomics Inc. (NEO) | 10-Aug-24 | Option Exercise | 11,336 | -- | -- | 110% 10.3K to 21.64K | |
| 13-Aug-24 4:32 PM View: | Kelly Michael Aaron Director | Neogenomics Inc. (NEO) | 10-Aug-24 | Option Exercise | 11,336 | -- | -- | 56% 20.42K to 31.75K | |
| 13-Aug-24 4:27 PM View: | Kanovsky Stephen M Director | Neogenomics Inc. (NEO) | 10-Aug-24 | Option Exercise | 11,336 | -- | -- | 46% 24.75K to 36.09K | |
| 13-Aug-24 4:21 PM View: | Gunn Neil Director | Neogenomics Inc. (NEO) | 10-Aug-24 | Option Exercise | 11,336 | -- | -- | 100% 0 to 11.34K | |
| 13-Aug-24 4:37 PM View: | Tetrault Lynn A. Director | Neogenomics Inc. (NEO) | 10-Aug-24 | Option Exercise | 11,336 | -- | -- | 23% 50.06K to 61.4K | |
| 13-Aug-24 4:40 PM View: | Zook Anthony P. Director | Neogenomics Inc. (NEO) | 10-Aug-24 | Option Exercise | 11,336 | -- | -- | 100% 0 to 11.34K | |
| 05-Aug-24 4:07 PM View: | Olivo Alicia C General Counsel | Neogenomics Inc. (NEO) | 01-Aug-24 | Payment of Exercise | 14 | -- | -- | (< 1%) 44.87K to 44.85K | |
| 17-May-24 4:07 PM View: | Olivo Alicia C General Counsel | Neogenomics Inc. (NEO) | 15-May-24 | Sale | 1,049 | $15.74 | $16,511.30 | (2%) 45.92K to 44.87K | |
| 14-May-24 9:39 PM View: | Olivo Alicia C General Counsel | Neogenomics Inc. (NEO) | 11-May-24 | Option Exercise | 13,004 | -- | -- | 38% 34.5K to 47.5K | |
| 14-May-24 9:38 PM View: | Sherman Jeffrey Scott Chief Financial Officer | Neogenomics Inc. (NEO) | 11-May-24 | Option Exercise | 26,010 | -- | -- | 21% 125.66K to 151.67K | |
| 14-May-24 9:39 PM View: | Smith Christopher M Chief Executive Officer | Neogenomics Inc. (NEO) | 11-May-24 | Option Exercise | 96,126 | -- | -- | 16% 602.22K to 698.35K | |
| 14-May-24 9:38 PM View: | Harris Melody Chf Ops Off, Pres, Informatics | Neogenomics Inc. (NEO) | 11-May-24 | Payment of Exercise | 1,722 | $14.86 | $25,588.90 | (2%) 110.02K to 108.3K | |
| 14-May-24 9:38 PM View: | Stone Warren Chief Commerical Officer | Neogenomics Inc. (NEO) | 11-May-24 | Option Exercise | 19,224 | -- | -- | 23% 83.78K to 103.0K | |
| 14-May-24 9:38 PM View: | Harris Melody Chf Ops Off, Pres, Informatics | Neogenomics Inc. (NEO) | 11-May-24 | Option Exercise | 7,068 | -- | -- | 7% 102.95K to 110.02K | |
| 14-May-24 9:39 PM View: | Olivo Alicia C General Counsel | Neogenomics Inc. (NEO) | 11-May-24 | Payment of Exercise | 1,584 | $14.86 | $23,538.20 | (3%) 47.5K to 45.92K | |
| 14-May-24 9:38 PM View: | Sherman Jeffrey Scott Chief Financial Officer | Neogenomics Inc. (NEO) | 11-May-24 | Payment of Exercise | 3,167 | $14.86 | $47,061.60 | (2%) 151.67K to 148.5K | |
| 14-May-24 9:39 PM View: | Smith Christopher M Chief Executive Officer | Neogenomics Inc. (NEO) | 11-May-24 | Payment of Exercise | 18,913 | $14.86 | $281,047.00 | (3%) 698.35K to 679.43K | |
| 14-May-24 9:38 PM View: | Stone Warren Chief Commerical Officer | Neogenomics Inc. (NEO) | 11-May-24 | Payment of Exercise | 2,341 | $14.86 | $34,787.30 | (2%) 103.0K to 100.66K | |
| 03-May-24 4:07 PM View: | Aunan Greg D Chief Accounting Officer | Neogenomics Inc. (NEO) | 01-May-24 | Payment of Exercise | 937 | -- | -- | (6%) 15.39K to 14.45K | |
| 03-May-24 4:10 PM View: | Olivo Alicia C General Counsel | Neogenomics Inc. (NEO) | 01-May-24 | Payment of Exercise | 652 | -- | -- | (2%) 35.15K to 34.5K | |
| 06-Mar-24 4:26 PM View: | Tetrault Lynn A. Director | Neogenomics Inc. (NEO) | 04-Mar-24 | Sale | 6,112 | $15.97 | $97,578.70 | (11%) 56.17K to 50.06K | |
| 20-Feb-24 4:32 PM View: | Olivo Alicia C General Counsel | Neogenomics Inc. (NEO) | 15-Feb-24 | Sale | 2,587 | $14.96 | $38,712.90 | (7%) 37.45K to 34.87K | |
| 03-Jan-24 5:28 PM View: | Harris Melody President, Enterprise Ops | Neogenomics Inc. (NEO) | 01-Jan-24 | Payment of Exercise | 7,123 | -- | -- | (6%) 110.08K to 102.95K | |
| 11-Dec-23 7:54 PM View: | Sherman Jeffrey Scott Chief Financial Officer | Neogenomics Inc. (NEO) | 07-Dec-23 | Payment of Exercise | 8,147 | -- | -- | (6%) 133.81K to 125.66K | |
| 05-Dec-23 4:49 PM View: | Stone Warren President, Clinical Services | Neogenomics Inc. (NEO) | 01-Dec-23 | Payment of Exercise | 5,431 | -- | -- | (6%) 89.21K to 83.78K | |
| 20-Nov-23 4:33 PM View: | Olivo Alicia C General Counsel | Neogenomics Inc. (NEO) | 17-Nov-23 | Sale | 2,669 | $18.39 | $49,082.90 | (7%) 39.81K to 37.14K | |
| 03-Oct-23 10:00 PM View: | Olivo Alicia C General Counsel | Neogenomics Inc. (NEO) | 30-Sep-23 | Payment of Exercise | 14 | -- | -- | (< 1%) 39.51K to 39.5K | |
| 05-Sep-23 5:27 PM View: | Olivo Alicia C General Counsel | Neogenomics Inc. (NEO) | 01-Sep-23 | Payment of Exercise | 1,666 | -- | -- | (4%) 41.08K to 39.41K | |
| 01-Aug-23 5:26 PM View: | Olivo Alicia C General Counsel | Neogenomics Inc. (NEO) | 01-Aug-23 | Payment of Exercise | 14 | -- | -- | (< 1%) 40.99K to 40.98K | |
| 02-Jun-23 6:01 PM View: | Sikri Vishal President Advanced Diagnostics | Neogenomics Inc. (NEO) | 01-Jun-23 | Payment of Exercise | 21,406 | -- | -- | (14%) 149.12K to 127.72K | |
| 24-May-23 5:29 PM View: | Tetrault Lynn A. Director | Neogenomics Inc. (NEO) | 22-May-23 | Option Exercise | 1,507 | $11.60 | $17,481.20 | 3% 54.67K to 56.17K | |
| 03-May-23 4:59 PM View: | Olivo Alicia C General Counsel | Neogenomics Inc. (NEO) | 01-May-23 | Payment of Exercise | 662 | -- | -- | (2%) 41.36K to 40.69K | |
| 04-Apr-23 5:04 PM View: | Kulkarni Shashikant Chief Scientific Officer | Neogenomics Inc. (NEO) | 01-Apr-23 | Payment of Exercise | 3,759 | -- | -- | (4%) 86.43K to 82.67K | |
| 03-Mar-23 5:34 PM View: | Dieter Cynthia J Chief Accounting Officer | Neogenomics Inc. (NEO) | 02-Mar-23 | Payment of Exercise | 117 | -- | -- | (< 1%) 29.88K to 29.77K | |
| 03-Mar-23 5:34 PM View: | Dieter Cynthia J Chief Accounting Officer | Neogenomics Inc. (NEO) | 01-Mar-23 | Payment of Exercise | 880 | -- | -- | (3%) 30.76K to 29.88K | |
| 04-Jan-23 5:39 PM View: | Harris Melody President, Enterprise Ops | Neogenomics Inc. (NEO) | 01-Jan-23 | Grant | 108,225 | -- | -- | 100% 0 to 108.22K | |
| 04-Jan-23 5:40 PM View: | Dieter Cynthia J Chief Accounting Officer | Neogenomics Inc. (NEO) | 31-Dec-22 | Payment of Exercise | 959 | -- | -- | (3%) 31.72K to 30.76K | |
| 01-Feb-23 10:00 PM View: | Sikri Vishal President, Pharma Services | Neogenomics Inc. (NEO) | 31-Dec-22 | Acquisition (small) | 225 | $7.04 | $1,584.00 | < 1% 148.46K to 148.68K | |
| 07-Dec-22 8:47 PM View: | Sherman Jeffrey Scott Chief Financial Officer | Neogenomics Inc. (NEO) | 05-Dec-22 | Grant | 133,809 | -- | -- | 100% 0 to 133.81K | |
| 05-Dec-22 9:23 PM View: | Stone Warren President, Clinical Services | Neogenomics Inc. (NEO) | 01-Dec-22 | Grant | 89,206 | -- | -- | 100% 0 to 89.21K | |
| 07-Nov-22 5:13 PM View: | Perez David Brian Director | Neogenomics Inc. (NEO) | 03-Nov-22 | Grant | 10,300 | -- | -- | 100% 0 to 10.3K | |
| 03-Nov-22 5:16 PM View: | Dieter Cynthia J Chief Accounting Officer | Neogenomics Inc. (NEO) | 01-Nov-22 | Grant | 13,141 | -- | -- | 71% 18.58K to 31.72K | |
| 17-Aug-22 7:13 PM View: | Smith Christopher M Chief Executive Officer | Neogenomics Inc. (NEO) | 15-Aug-22 | Grant | 602,219 | -- | -- | 100% 0 to 602.22K | |
| 03-Aug-22 5:44 PM View: | Kulkarni Shashikant President of Lab Operations | Neogenomics Inc. (NEO) | 01-Aug-22 | Grant | 24,704 | -- | -- | 60% 41.15K to 65.86K | |
| 03-Aug-22 5:45 PM View: | Sholehvar David President, Clinical Services | Neogenomics Inc. (NEO) | 01-Aug-22 | Grant | 12,352 | -- | -- | 40% 30.86K to 43.22K | |
| 24-Jun-22 5:07 PM View: | Dieter Cynthia J Chief Accounting Officer | Neogenomics Inc. (NEO) | 22-Jun-22 | Payment of Exercise | 57 | -- | -- | (< 1%) 18.64K to 18.58K |
